Beng Yang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Extracellular vesicles in disease
Papers in
-
- MicroRNA in disease regulation 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Jian Wu (13 shared papers)Shusen Zheng (15 shared papers)Junru Chen (6 shared papers)Rongliang Tong (14 shared papers)Yunhao Chen (6 shared papers)Haiyang Xie (10 shared papers)Yanpeng Zhang (4 shared papers)Lin Zhou (5 shared papers)
- Journals
- International Journal of Oncology (2 papers)Cancer Letters (2 papers)Molecular Cancer (2 papers)Cell Death and Disease (2 papers)Advanced Science (2 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Beng Yang
26 papers receiving 1.9k citations
Beng Yang's Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 342
- Molecular Biology 962
- Inorganic Chemistry 170
- Hepatology 99
- Biomaterials 88
Countries citing papers authored by Beng Yang
This map shows the geographic impact of Beng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beng Yang more than expected).
Fields of papers citing papers by Beng Yang
This network shows the impact of papers produced by Beng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beng Yang. The network helps show where Beng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Beng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 Hit paper breakdown → | 2019 | 501 |
| 2 | 2017 | 318 | |
| 3 | 2020 | 219 | |
| 4 | 2019 | 153 | |
| 5 | 2020 | 152 | |
| 6 | Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion Hit paper breakdown → | 2023 | 106 |
| 7 | 2020 | 75 | |
| 8 | 2021 | 67 | |
| 9 | 2019 | 54 | |
| 10 | 2018 | 45 | |
| 11 | 2019 | 41 | |
| 12 | 2023 | 30 | |
| 13 | 2019 | 28 | |
| 14 | 2023 | 28 | |
| 15 | 2016 | 25 | |
| 16 | 2018 | 23 | |
| 17 | 2024 | 23 | |
| 18 | 2023 | 22 | |
| 19 | 2017 | 17 | |
| 20 | Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway. | 2019 | 16 |
About Beng Yang
Beng Yang is a scholar working on Cancer Research, Hepatology, Molecular Biology, Surgery and Biomaterials, having authored 27 papers that have together received 2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), RNA modifications and cancer (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Autophagy in Disease and Therapy (2 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (342 citations), Molecular Biology (962 citations), Inorganic Chemistry (170 citations), Hepatology (99 citations) and Biomaterials (88 citations). Beng Yang has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Jian Wu, Shusen Zheng, Junru Chen, Rongliang Tong, Yunhao Chen, Haiyang Xie, Yanpeng Zhang, Lin Zhou, Chuanhui Peng and Wendi Hu. Their work appears in journals such as International Journal of Oncology, Cancer Letters, Molecular Cancer, Cell Death and Disease and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.